M&A Deal Summary |
|
|---|---|
| Date | 2024-03-05 |
| Target | SoftCo |
| Sector | Software |
| Buyer(s) | Keensight Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 5.5B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 50 of 53 |
| Sector: Software M&A | 10 of 10 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 18 of 19 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2024 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-02-06 |
Plat4mation
Utrecht, Netherlands Plat4mation is a global pure-play ServiceNow Elite partner. The Company helps ServiceNow customers across the entire value chain, offering a comprehensive suite of advisory, implementation, and managed services solutions. Plat4mation was founded in 2013 and is based in Utrecht, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-09-17 |
Isto Biologics
Hopkinton, Massachusetts, United States Isto Biologics is an orthobiologics company providing advanced solutions for the spine and orthopedics markets. Isto Biologics offers an innovative portfolio of products, including InQu Bone Graft Extender & Substitute, Influx Trabecular Bone Graft, and CellPoint Concentrated Bone Marrow Aspirate System. Isto Biologics was founded in 2016 and is based in Hopkinton, Massachusetts. |
Buy | - |